The invention

The invention
AI-DoLPHIN: Multi-omics platform for next-gen probiotics/therapeutics for NCDs

AI-DoLPHIN: Multi-omics platform for next-gen probiotics/therapeutics for NCDs

The invention

Name of invention
AI-DoLPHIN: Multi-omics platform for next-gen probiotics/therapeutics for NCDs
AI-DoLPHIN : Plateforme multi-omiques pour probiotiques/thérapeutiques de nouvelle génération pour maladies non transmissibles

Invention description

Description
An AI-driven platform (DoLPHIN) developed to analyze multi-omics data from a huge mother-baby cohort, with over 130,000 samples from 2,000+ families, aiming to create next-generation probiotics and live biotherapeutics to combat NCDs.

Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.